Ming Tsao

Alıntı yapanlar

	Hepsi	2020 yılından bugüne
Alıntılar	116576	48330
h-endeksi	151	90
i10-endeksi	612	441

11000

5500

2750

8250

2001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025357 472 520 667 875 1287 1680 1950 2076 2602 3215 4077 4787 5467 5708 6349 6817 7860 8153 9381 10138 9967 8966 8646 1190

Genel erişim

Tümünü görüntüle

267 makale

32 makale

genel erişime açık olanlar

genel erişime açık olmayanlar

Finansman sağlayan kuruluşun getirdiği zorunluluğa dayalı olarak

Katkıda bulunan yazarlar

Natasha LeighlMedical Oncology, Princess Margaretuhn.ca üzerinde doğrulanmış e-posta adresine sahip
TK WaddellDivision of Thoracic Surgery, University of Torontouhn.ca üzerinde doğrulanmış e-posta adresine sahip
Michael F. (Mike) MoranProfessor of Molecular Genetics, University of Torontoutoronto.ca üzerinde doğrulanmış e-posta adresine sahip
Paul C. BoutrosUniversity of California, Los Angelesmednet.ucla.edu üzerinde doğrulanmış e-posta adresine sahip
Shaf Keshavjee MDDoctors of Thoracic Surgery, Toronto General Hospital, UHNuhn.ca üzerinde doğrulanmış e-posta adresine sahip
Bradley P CoeLaboratory Scientist, BC Children's and Women's Hospitalcw.bc.ca üzerinde doğrulanmış e-posta adresine sahip
Dongsheng TuProfessor of Biostatistics, Queen's University at Kingston, Canadactg.queensu.ca üzerinde doğrulanmış e-posta adresine sahip
Warren ShihMedical Laboratory Technologist, Alpha Labsutoronto.ca üzerinde doğrulanmış e-posta adresine sahip
Pierre HainautProfessor, Cancer Biology, University Grenoble Alpes and Director, Institute for Advanceduniv-grenoble-alpes.fr üzerinde doğrulanmış e-posta adresine sahip
William LockwoodDistinguished Scientist, British Columbia Cancer Agency - Professor, University of British Columbiabccrc.ca üzerinde doğrulanmış e-posta adresine sahip
Toru FurukawaTohoku Universitymed.tohoku.ac.jp üzerinde doğrulanmış e-posta adresine sahip
Vladimir IakovlevPathologist, St. Michael's Hospital; Assistant Professor, Laboratory Medicine and Pathobiologysmh.ca üzerinde doğrulanmış e-posta adresine sahip

Takip et

Ming Tsao

University of Toronto, University Health Network, Princess Margaret Cancer Centre

uhn.ca üzerinde doğrulanmış e-posta adresine sahip

molecular pathology lung cancer translational research pancreatic cancer


Başlık Alıntılara göre sırala Yıla göre sırala Başlığa göre sırala	Alıntı yapanlar Alıntı yapanlar	Yıl
International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma WD Travis, E Brambilla, M Noguchi, AG Nicholson, KR Geisinger, ... Journal of thoracic oncology 6 (2), 244-285, 2011	6226	2011
The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification WD Travis, E Brambilla, AG Nicholson, Y Yatabe, JHM Austin, ... Journal of thoracic oncology 10 (9), 1243-1260, 2015	4994	2015
Comprehensive molecular profiling of lung adenocarcinoma Cancer Genome Atlas Research Network Nature 511 (7511), 543, 2014	4940*	2014
The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer P Goldstraw, K Chansky, J Crowley, R Rami-Porta, H Asamura, ... Journal of Thoracic Oncology 11 (1), 39-51, 2016	4528	2016
The landscape of somatic copy-number alteration across human cancers R Beroukhim, CH Mermel, D Porter, G Wei, S Raychaudhuri, J Donovan, ... Nature 463 (7283), 899-905, 2010	4507	2010
Comprehensive genomic characterization of squamous cell lung cancers CGAR Network Nature 489 (7417), 519-25, 2012	3839	2012
Vinorelbine plus cisplatin vs. observation in resected non–small-cell lung cancer T Winton, R Livingston, D Johnson, J Rigas, M Johnston, C Butts, ... New England Journal of Medicine 352 (25), 2589-2597, 2005	2354	2005
Erlotinib in lung cancer—molecular and clinical predictors of outcome MS Tsao, A Sakurada, JC Cutz, CQ Zhu, S Kamel-Reid, J Squire, ... New England Journal of Medicine 353 (2), 133-144, 2005	2322	2005
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes AV Biankin, N Waddell, KS Kassahn, MC Gingras, LB Muthuswamy, ... Nature 491 (7424), 399-405, 2012	2283	2012
Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation KP Hoeflich, J Luo, EA Rubie, MS Tsao, OU Jin, JR Woodgett Nature 406 (6791), 86-90, 2000	1839	2000
Updated molecular testing guideline for the selection of lung cancer patients for treatment with targeted tyrosine kinase inhibitors: guideline from the College of American … NI Lindeman, PT Cagle, DL Aisner, ME Arcila, MB Beasley, EH Bernicker, ... Archives of pathology & laboratory medicine 142 (3), 321-346, 2018	1645	2018
Probability of cancer in pulmonary nodules detected on first screening CT A McWilliams, MC Tammemagi, JR Mayo, H Roberts, G Liu, K Soghrati, ... New England journal of medicine 369 (10), 910-919, 2013	1440	2013
PD-L1 immunohistochemistry assays for lung cancer: results from phase 1 of the blueprint PD-L1 IHC assay comparison project FR Hirsch, A McElhinny, D Stanforth, J Ranger-Moore, M Jansson, ... Journal of Thoracic Oncology 12 (2), 208-222, 2017	1338	2017
Characterizing the cancer genome in lung adenocarcinoma BA Weir, MS Woo, G Getz, S Perner, L Ding, R Beroukhim, WM Lin, ... Nature 450 (7171), 893-898, 2007	1300	2007
Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas JD Campbell, A Alexandrov, J Kim, J Wala, AH Berger, CS Pedamallu, ... Nature genetics 48 (6), 607-616, 2016	1225	2016
Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study Nature medicine 14 (8), 822-827, 2008	1152	2008
SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas AJ Bass, H Watanabe, CH Mermel, S Yu, S Perner, RG Verhaak, SY Kim, ... Nature genetics 41 (11), 1238-1242, 2009	1101	2009
PD-L1 as a biomarker of response to immune-checkpoint inhibitors DB Doroshow, S Bhalla, MB Beasley, LM Sholl, KM Kerr, S Gnjatic, ... Nature reviews Clinical oncology 18 (6), 345-362, 2021	1098	2021
EGFR mutations and lung cancer G da Cunha Santos, FA Shepherd, MS Tsao Annual Review of Pathology: Mechanisms of Disease 6 (1), 49-69, 2011	1003	2011
An overview of the c-MET signaling pathway SL Organ, MS Tsao Therapeutic advances in medical oncology 3 (1_suppl), S7-S19, 2011	993	2011

Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.

Makaleler 1–20

Yıllık alıntı sayısı

Mükerrer alıntılar

Birleştirilmiş alıntılar

Katkıda bulunan yazar ekleKatkıda bulunan yazarlar

Takip et

Alıntı yapanlar

Katkıda bulunan yazarlar